Agreed. Also, if they intended to stay independent they would have at least started to put some job postings for sales, marketing & business development team, considering they are sitting on the cusp of a major disruptive technology reveal and imminent change of standard of care. Companies start hiring months and months in advance to start training their staff. I’d have expected them to start making moves in this direction in UK and EU region at the very least given that approval there is 99% certain! Again, speaking from personal experience in neurology space and having gone through an acquisition few years back. They are doing nothing!
I wouldn’t trust anyone that says they don’t need a sales/marketing and business dev team to promote and capture market share for DCVAX-L regardless of how good the results and technology are both in terms of safety and efficacy. Just doesn’t work that way in the real healthcare world.
Market Data 
Markets 
AI
